Oncology & Cancer

Host immune classifier HIC assays may predict treatment response

Using a host immune classifier (HIC) test for patients with non-small cell lung cancer (NSCLC) may provide better predictors of treatment response and improve outcomes, according to research presented today at the International ...

Oncology & Cancer

New Zealanders need high quality cancer information

There is considerable demand for cancer information resources in New Zealand, with a third of women and a quarter of men deliberately searching for these over the past year, according to a new University of Otago study.

page 23 from 26